T1	AdverseReaction 720 746	Increases in liver enzymes
T8	AdverseReaction 1028 1040	hypertension
T9	AdverseReaction 1042 1053	hypokalemia
T10	AdverseReaction 1059 1074	fluid retention
T11	AdverseReaction 1095 1129	increased mineralocorticoid levels
T20	AdverseReaction 2482 2503	Adrenal insufficiency
T21	AdverseReaction 2626 2654	Adrenocortical insufficiency
T32	AdverseReaction 3115 3139	mineralocorticoid excess
T38	AdverseReaction 3835 3857	liver enzyme increases
T39	AdverseReaction 3957 3971	hepatotoxicity
T13	AdverseReaction 1252 1264	hypertension
T14	Severity 1239 1246	grade 3
T15	Severity 1239 1244;1250 1251	grade 4
T16	AdverseReaction 1306 1317	hypokalemia
T17	Severity 1293 1300	grade 3
T18	Severity 1293 1298;1304 1305	grade 4
T44	AdverseReaction 1354 1359	edema
T45	Severity 1341 1348	grade 3
T46	Severity 1341 1346;1352 1353	grade 4
T31	AdverseReaction 3035 3063	adrenocortical insufficiency
T56	AdverseReaction 3513 3526	AST increases
T57	AdverseReaction 3506 3509;3517 3526	ALT increases
T58	Severity 3493 3500	grade 3
T59	Severity 3493 3498;3504 3505	grade 4
T60	AdverseReaction 3740 3760	liver test elevation
T61	AdverseReaction 3903 3909	deaths
T62	Negation 3900 3902	No
T26	Factor 1018 1021	may
T2	AdverseReaction 50 74	Mineralocorticoid excess
T3	AdverseReaction 499 527	Adrenocortical insufficiency
T4	AdverseReaction 704 718	Hepatotoxicity
T5	Severity 1239 1251	grade 3 to 4
T6	Severity 1293 1305	grade 3 to 4
T7	Severity 1341 1353	grade 3 to 4
E1	AdverseReaction:T1
E8	AdverseReaction:T8 Hypothetical:E26
E9	AdverseReaction:T9 Hypothetical:E26
E10	AdverseReaction:T10 Hypothetical:E26
E11	AdverseReaction:T11
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E32	AdverseReaction:T32
E38	AdverseReaction:T38
E39	AdverseReaction:T39
E13	AdverseReaction:T13 Effect:E14 Effect2:E15 Effect3:E5
E14	Severity:T14
E15	Severity:T15
E16	AdverseReaction:T16 Effect:E17 Effect2:E18 Effect3:E6
E17	Severity:T17
E18	Severity:T18
E44	AdverseReaction:T44 Effect:E45 Effect2:E46 Effect3:E7
E45	Severity:T45
E46	Severity:T46
E31	AdverseReaction:T31
E57	AdverseReaction:T56 Effect:E60 Effect2:E59
E58	AdverseReaction:T57 Effect:E60 Effect2:E59
E59	Severity:T58
E60	Severity:T59
E61	AdverseReaction:T60
E62	AdverseReaction:T61 Negated:E63
E63	Negation:T62
E26	Factor:T26
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	Severity:T5
E6	Severity:T6
E7	Severity:T7
A1	CUI E1 C0235996
A2	UMLS-Preferred-Name E1 Elevated liver enzymes
A3	MEDDRA-PT E1 Hepatic enzyme increased
A4	MEDDRA-PT-ID E1 10060795
A5	LLT E1 Elevated liver enzymes
A6	LLT-ID E1 10014481
A7	CUI E8 C0020538
A8	UMLS-Preferred-Name E8 Hypertensive disease
A9	MEDDRA-PT E8 Hypertension
A10	MEDDRA-PT-ID E8 10020772
A11	CUI E9 C0020621
A12	UMLS-Preferred-Name E9 Hypokalemia
A13	MEDDRA-PT E9 Hypokalaemia
A14	MEDDRA-PT-ID E9 10021015
A15	LLT E9 Hypokalemia
A16	LLT-ID E9 10021018
A17	CUI E10 C0268000
A18	UMLS-Preferred-Name E10 Body fluid retention
A19	MEDDRA-PT E10 Fluid retention
A20	MEDDRA-PT-ID E10 10016807
A21	CUI E11 C0001622
A22	UMLS-Preferred-Name E11 Adrenal Gland Hyperfunction
A23	MEDDRA-PT E11 Hypercorticoidism
A24	MEDDRA-PT-ID E11 10020610
A25	CUI E20 C0001623
A26	UMLS-Preferred-Name E20 Adrenal gland hypofunction
A27	MEDDRA-PT E20 Adrenal insufficiency
A28	MEDDRA-PT-ID E20 10001367
A29	CUI E21 C0405580
A30	UMLS-Preferred-Name E21 Adrenal cortical hypofunction
A31	MEDDRA-PT E21 Adrenal insufficiency
A32	MEDDRA-PT-ID E21 10001367
A33	LLT E21 Adrenal cortex insufficiency
A34	LLT-ID E21 10001335
A35	CUI E32 C0020428
A36	UMLS-Preferred-Name E32 Hyperaldosteronism
A37	MEDDRA-PT E32 Hyperaldosteronism
A38	MEDDRA-PT-ID E32 10020571
A39	CUI E38 C0235996
A40	UMLS-Preferred-Name E38 Elevated liver enzymes
A41	MEDDRA-PT E38 Hepatic enzyme increased
A42	MEDDRA-PT-ID E38 10060795
A43	LLT E38 Elevated liver enzymes
A44	LLT-ID E38 10014481
A45	CUI E39 C0235378
A46	UMLS-Preferred-Name E39 Hepatotoxicity
A47	MEDDRA-PT E39 Hepatotoxicity
A48	MEDDRA-PT-ID E39 10019851
A49	CUI E13 C0020538
A50	UMLS-Preferred-Name E13 Hypertensive disease
A51	MEDDRA-PT E13 Hypertension
A52	MEDDRA-PT-ID E13 10020772
A53	CUI E16 C0020621
A54	UMLS-Preferred-Name E16 Hypokalemia
A55	MEDDRA-PT E16 Hypokalaemia
A56	MEDDRA-PT-ID E16 10021015
A57	LLT E16 Hypokalemia
A58	LLT-ID E16 10021018
A59	CUI E44 C0013604
A60	UMLS-Preferred-Name E44 Edema
A61	MEDDRA-PT E44 Oedema
A62	MEDDRA-PT-ID E44 10030095
A63	LLT E44 Edema
A64	LLT-ID E44 10014210
A65	CUI E31 C0405580
A66	UMLS-Preferred-Name E31 Adrenal cortical hypofunction
A67	MEDDRA-PT E31 Adrenal insufficiency
A68	MEDDRA-PT-ID E31 10001367
A69	LLT E31 Adrenal cortex insufficiency
A70	LLT-ID E31 10001335
A71	CUI E57 C0151904
A72	UMLS-Preferred-Name E57 Aspartate aminotransferase increased
A73	MEDDRA-PT E57 Aspartate aminotransferase increased
A74	MEDDRA-PT-ID E57 10003481
A75	LLT E57 AST increased
A76	LLT-ID E57 10003544
A77	CUI E58 C0151905
A78	UMLS-Preferred-Name E58 Alanine aminotransferase increased
A79	MEDDRA-PT E58 Alanine aminotransferase increased
A80	MEDDRA-PT-ID E58 10001551
A81	LLT E58 ALT increased
A82	LLT-ID E58 10001845
A83	CUI E61 C0877359
A84	UMLS-Preferred-Name E61 Increased liver function tests
A85	MEDDRA-PT E61 Liver function test abnormal
A86	MEDDRA-PT-ID E61 10024690
A87	LLT E61 Liver function tests raised
A88	LLT-ID E61 10048556
A89	CUI E62 C1306577
A90	UMLS-Preferred-Name E62 Death (finding)
A91	MEDDRA-PT E62 Death
A92	MEDDRA-PT-ID E62 10011906
A93	CUI E2 C0020428
A94	UMLS-Preferred-Name E2 Hyperaldosteronism
A95	MEDDRA-PT E2 Hyperaldosteronism
A96	MEDDRA-PT-ID E2 10020571
A97	CUI E3 C0405580
A98	UMLS-Preferred-Name E3 Adrenal cortical hypofunction
A99	MEDDRA-PT E3 Adrenal insufficiency
A100	MEDDRA-PT-ID E3 10001367
A101	LLT E3 Adrenal cortex insufficiency
A102	LLT-ID E3 10001335
A103	CUI E4 C0235378
A104	UMLS-Preferred-Name E4 Hepatotoxicity
A105	MEDDRA-PT E4 Hepatotoxicity
A106	MEDDRA-PT-ID E4 10019851
